vs
Side-by-side financial comparison of ARMSTRONG WORLD INDUSTRIES INC (AWI) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($761.7M vs $388.3M, roughly 2.0× ARMSTRONG WORLD INDUSTRIES INC). ARMSTRONG WORLD INDUSTRIES INC runs the higher net margin — 16.9% vs 12.0%, a 4.9% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 5.6%). Insulet Corporation produced more free cash flow last quarter ($89.5M vs $62.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (24.9% CAGR vs 9.1%).
Armstrong World Industries, Inc. is an international designer and manufacturer of wall and ceiling building materials based in Lancaster, Pennsylvania. As of 2014, AWI had 3,100 employees and a global manufacturing network of 17 facilities, down from 26, including nine plants dedicated to its WAVE joint venture, in 2012.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
AWI vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $388.3M | $761.7M |
| Net Profit | $65.5M | $91.1M |
| Gross Margin | 39.8% | 69.5% |
| Operating Margin | 23.7% | 16.0% |
| Net Margin | 16.9% | 12.0% |
| Revenue YoY | 5.6% | 33.9% |
| Net Profit YoY | 5.3% | 157.3% |
| EPS (diluted) | $1.51 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $761.7M | ||
| Q4 25 | $388.3M | $783.7M | ||
| Q3 25 | $425.2M | $706.3M | ||
| Q2 25 | $424.6M | $649.1M | ||
| Q1 25 | $382.7M | $569.0M | ||
| Q4 24 | $367.7M | $597.5M | ||
| Q3 24 | $386.6M | $543.9M | ||
| Q2 24 | $365.1M | $488.5M |
| Q1 26 | — | $91.1M | ||
| Q4 25 | $65.5M | $101.6M | ||
| Q3 25 | $86.3M | $87.6M | ||
| Q2 25 | $87.8M | $22.5M | ||
| Q1 25 | $69.1M | $35.4M | ||
| Q4 24 | $62.2M | $100.7M | ||
| Q3 24 | $76.9M | $77.5M | ||
| Q2 24 | $65.9M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | 39.8% | 72.6% | ||
| Q3 25 | 42.0% | 72.2% | ||
| Q2 25 | 41.4% | 69.7% | ||
| Q1 25 | 39.2% | 71.9% | ||
| Q4 24 | 39.1% | 72.1% | ||
| Q3 24 | 42.4% | 69.3% | ||
| Q2 24 | 40.9% | 67.7% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 23.7% | 18.7% | ||
| Q3 25 | 27.6% | 16.7% | ||
| Q2 25 | 29.0% | 18.7% | ||
| Q1 25 | 25.7% | 15.6% | ||
| Q4 24 | 22.3% | 18.3% | ||
| Q3 24 | 28.8% | 16.2% | ||
| Q2 24 | 26.0% | 11.2% |
| Q1 26 | — | 12.0% | ||
| Q4 25 | 16.9% | 13.0% | ||
| Q3 25 | 20.3% | 12.4% | ||
| Q2 25 | 20.7% | 3.5% | ||
| Q1 25 | 18.1% | 6.2% | ||
| Q4 24 | 16.9% | 16.9% | ||
| Q3 24 | 19.9% | 14.2% | ||
| Q2 24 | 18.0% | 38.6% |
| Q1 26 | — | $1.30 | ||
| Q4 25 | $1.51 | $1.42 | ||
| Q3 25 | $1.98 | $1.24 | ||
| Q2 25 | $2.01 | $0.32 | ||
| Q1 25 | $1.58 | $0.50 | ||
| Q4 24 | $1.41 | $1.38 | ||
| Q3 24 | $1.75 | $1.08 | ||
| Q2 24 | $1.50 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.7M | $480.4M |
| Total DebtLower is stronger | — | $18.6M |
| Stockholders' EquityBook value | $900.7M | $1.3B |
| Total Assets | $1.9B | $3.0B |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $480.4M | ||
| Q4 25 | $112.7M | — | ||
| Q3 25 | $90.1M | — | ||
| Q2 25 | $81.1M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | $79.3M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $73.6M | — |
| Q1 26 | — | $18.6M | ||
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $900.7M | $1.5B | ||
| Q3 25 | $889.2M | $1.4B | ||
| Q2 25 | $837.8M | $1.5B | ||
| Q1 25 | $793.4M | $1.3B | ||
| Q4 24 | $757.1M | $1.2B | ||
| Q3 24 | $717.0M | $1.1B | ||
| Q2 24 | $669.0M | $998.4M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $1.9B | $3.2B | ||
| Q3 25 | $1.9B | $3.0B | ||
| Q2 25 | $1.9B | $3.5B | ||
| Q1 25 | $1.9B | $3.5B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.8B | $3.0B | ||
| Q2 24 | $1.8B | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $110.0M | $113.8M |
| Free Cash FlowOCF − Capex | $62.2M | $89.5M |
| FCF MarginFCF / Revenue | 16.0% | 11.8% |
| Capex IntensityCapex / Revenue | 12.3% | 3.2% |
| Cash ConversionOCF / Net Profit | 1.68× | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | $246.1M | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $113.8M | ||
| Q4 25 | $110.0M | $183.3M | ||
| Q3 25 | $122.9M | $125.7M | ||
| Q2 25 | $81.6M | $196.5M | ||
| Q1 25 | $41.0M | $63.8M | ||
| Q4 24 | $86.6M | $147.7M | ||
| Q3 24 | $96.5M | $98.5M | ||
| Q2 24 | $57.3M | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | $62.2M | $48.2M | ||
| Q3 25 | $100.3M | $100.1M | ||
| Q2 25 | $61.7M | $177.9M | ||
| Q1 25 | $21.9M | $51.5M | ||
| Q4 24 | $57.8M | $94.1M | ||
| Q3 24 | $77.1M | $71.8M | ||
| Q2 24 | $37.4M | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | 16.0% | 6.2% | ||
| Q3 25 | 23.6% | 14.2% | ||
| Q2 25 | 14.5% | 27.4% | ||
| Q1 25 | 5.7% | 9.1% | ||
| Q4 24 | 15.7% | 15.7% | ||
| Q3 24 | 19.9% | 13.2% | ||
| Q2 24 | 10.2% | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 12.3% | 17.2% | ||
| Q3 25 | 5.3% | 3.6% | ||
| Q2 25 | 4.7% | 2.9% | ||
| Q1 25 | 5.0% | 2.2% | ||
| Q4 24 | 7.8% | 9.0% | ||
| Q3 24 | 5.0% | 4.9% | ||
| Q2 24 | 5.5% | 4.6% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | 1.68× | 1.80× | ||
| Q3 25 | 1.42× | 1.43× | ||
| Q2 25 | 0.93× | 8.73× | ||
| Q1 25 | 0.59× | 1.80× | ||
| Q4 24 | 1.39× | 1.47× | ||
| Q3 24 | 1.25× | 1.27× | ||
| Q2 24 | 0.87× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWI
| Distributors | $183.0M | 47% |
| Architectural Specialties | $143.7M | 37% |
| Home Centers | $27.2M | 7% |
| Retailers And Other | $21.7M | 6% |
| Direct Customers | $12.7M | 3% |
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
